OMEICOS Therapeutics is Biotechnology in Germany that focus on developer business. Founded in 2013. They cover business area such as developer, small molecule therapeutic technology, treatment, cardiovascular and ophthalmic disease, metabolically robust, synthetic analog, epoxyeicosanoid, metabolite, inflammatory, anti-arrhythmic and cardioprotective pathway, heart cell, cardiologist, cardiovascular disease.
2013
( 11 years old in 2024 )
Developer
-
Robert-Rössle-Straße 10
Building 79
13125 Berlin
Germany
Private
developersmall molecule therapeutic technologytreatmentcardiovascular and ophthalmic diseasemetabolically robust, synthetic analogepoxyeicosanoidmetaboliteinflammatory, anti-arrhythmic and cardioprotective pathwayheart cellcardiologistcardiovascular disease
* We use standard office opening hours in near OMEICOS Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
OMEICOS Therapeutics is Biotechnology business from Germany that founded in 2013 (11 years old in 2024), OMEICOS Therapeutics business is focusing on Developer.
OMEICOS Therapeutics headquarter office and corporate office address is located in Robert-Rössle-Straße 10 Building 79 13125 Berlin Germany.
OMEICOS Therapeutics was founded in Germany.
In 2024, OMEICOS Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with OMEICOS Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
